Navigation Links
King's-led consortium wins €1 million EU funding for Chinese medicine research
Date:5/5/2009

The project entitled 'Good Practice in Traditional Chinese Medicine Research in the Post-genomic Era' (GP-TCM) will review the current status of Traditional Chinese Medicine (TCM) research, identify problems and propose solutions by applying modern methods of investigation, as well as providing a forum for the exchange of opinions, experience and expertise among scientists in the EU and China.

The three-year project aims to propose guidelines and priority areas for future research, and will lead to the formation of a new academic society, the European Society of TCM Research, which is to facilitate and foster sustainable EU-China collaboration in this area.

The research consortium consists of 29 beneficiary partner institutions and small-and-medium-sized enterprises from the EU and China. Partnerships with more than 20 additional non-beneficiary institutions, companies and independent experts are further strengthening its research.

Holistic approach

Dr Qihe Xu, Lecturer in the Department of Renal Medicine, Division of Gene and Cell Based Therapy, and coordinator of the project, explains: 'In contrast to the reductionist approach of Western medicine that is based on modern anatomy and cell and molecular biology, TCM uses a unique theory system and an individualised holistic approach to describe health and disease, which is based on the philosophy of Yin-Yang balance. These two medicine systems disagree with each other in many situations since they observe health from their own limited perspective. GP-TCM aims to inform best practice and harmonise research of the safety and efficacy of TCM, especially Chinese herbal medicines and acupuncture, in the EU.'

'The project will be divided into ten parts, which will review aspects of quality control, extraction and analysis of Chinese herbal medicines. Discussion fora that explore the role of functional genomics methodology in researching the safety, efficacy and me
'/>"/>

Contact: Melanie Haberstroh
melanie.haberstroh@kcl.ac.uk
44-207-848-3076
King's College London
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Autism Consortium releases data on genes involved in autism to researchers worldwide
2. UMass Consortium awarded $300,000 from Juvenile Diabetes Research Foundation and Iacocca Foundation
3. Elan Pharmaceuticals Joins GeneGos MetaTox Consortium
4. Consortium Health Plans Cuts Down on Power Usage and Cooling in Its Data Center Using ONStors Green Clustered NAS Solution
5. Gordon & Rees LLP Joins ArlenGroup-CIGNA Health Care Purchasing Consortium
6. International consortium announces the 1000 Genomes Project
7. Cancer Vaccine Consortium and Cancer Vaccine Collaborative unite under the Cancer Research Institute
8. Geriatric Oncology Consortium (GOC) Announces Tampa Bay Road Rally to Raise Awareness for the Treatment of Seniors With Cancer
9. Siemens Consortium to Construct Particle Therapy Center at the University Clinic of Schleswig-Holstein
10. SAE-Funded CAESAR(TM) Project Earns Federal Laboratory Consortium Award
11. Neuroscience Peer Review Consortium announces increased journal participation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... ... July 03, 2015 , ... Scientists at several top US ... with even minimal asbestos exposure. Click here to read the complete story , ... Hawaii Cancer Center, Cedars Sinai Medical Center, and New York University exposed mice with ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Renowned ... the dates for the 2016 Dallas Rhinoplasty Symposium . To be held from ... the meeting will be held at the Westin Galleria Dallas. , Designed to take ...
(Date:7/3/2015)... LENEXA, Kan. (PRWEB) , ... July 03, 2015 ... ... firm dedicated exclusively to healthcare providers, has been retained to lead a national ... the top-ranked executive search firms in the healthcare industry, B. E. Smith has ...
(Date:7/3/2015)... KS (PRWEB) , ... July 03, 2015 , ... ... dedicated exclusively to healthcare providers, has been retained to lead a national ... One of the top-ranked executive search firms in the healthcare industry, B. E. ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... ... Lecture took place on June 25, 2015 at 1:00pm. The Association welcomed speaker ... issues pertaining to injured bicyclists and practical points of investigating these types of ...
Breaking Medicine News(10 mins):Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2
... the institute of nuclear medicine and chair of nuclear ... the 2008 Georg Charles de Hevesy Nuclear Pioneer Award ... award was presented during SNM,s 55th Annual Meetingthe world,s ... , "With this award, SNM recognizes Dr. Ell,s pioneering ...
... of free web meeting software has recently added advanced features like shared ... far, these features were only available for a high cost with paid ... Desktop Service, which lets you log into your home or office PC ... ...
... Dr. Michael Law a board certified plastic surgeon in Raleigh North ... of lipostructure in facial plastic surgery; Structural fat grafting with lipostructure ... by restoring a youthful but subtle facial fullness, says Dr. Law ... ...
... can be common side effect , , TUESDAY, July 22 (HealthDay ... way to erase telltale signs of aging on your face ... a fairly high rate of complications, namely lightening of the ... the July/August issue of Archives of Facial Plastic Surgery ...
... For patients with head and neck cancer, accurately determining ... means undergoing numerous tests until now. New Saint Louis ... used as a stand-alone tool to detect secondary cancers, which ... cancer patients. , The study findings, which will be presented ...
... LASIK Surgeons launched its revolutionary Trusted LASIK Surgeons ... www.TrustedLASIKSurgeons.com . What sets the Trusted LASIK ... that helps ensure only those LASIK surgeon who ... listed. Refractive surgeons such as Chicago LASIK Surgeon ...
Cached Medicine News:Health News:Peter Ell receives SNM's Georg Charles de Hevesy Nuclear Pioneer Award 2Health News:Peter Ell receives SNM's Georg Charles de Hevesy Nuclear Pioneer Award 3Health News:How to Conduct Free Web Meetings and Remote Desktop? 2Health News:Fat Grafting Provides Permanent, Natural Looking Results - Dr. Michael Law Explains Fat Injections as a New Trend in Facial Plastic Surgery 2Health News:Laser Resurfacing Produces Long-Term Results 2Health News:Laser Resurfacing Produces Long-Term Results 3Health News:Has cancer spread? Research identifies best way to find answers so treatment can begin 2Health News:Trusted LASIK Surgeons Welcomes Top LASIK Expert Randy Epstein, M.D. of Chicago to it's Unique Lasik Directory Service 2Health News:Trusted LASIK Surgeons Welcomes Top LASIK Expert Randy Epstein, M.D. of Chicago to it's Unique Lasik Directory Service 3Health News:Trusted LASIK Surgeons Welcomes Top LASIK Expert Randy Epstein, M.D. of Chicago to it's Unique Lasik Directory Service 4Health News:Trusted LASIK Surgeons Welcomes Top LASIK Expert Randy Epstein, M.D. of Chicago to it's Unique Lasik Directory Service 5Health News:Trusted LASIK Surgeons Welcomes Top LASIK Expert Randy Epstein, M.D. of Chicago to it's Unique Lasik Directory Service 6
(Date:7/3/2015)... , July 3, 2015 ... with Broda Technologies Co., Ltd., operating in both the ... the company,s proprietary IntelliGel ® supramolecular hydrogel technology ... development and other ophthalmic therapies. The Broda technology offers ... solution is a free-forming liquid and with low concentrations ...
(Date:7/2/2015)... TX and VANCOUVER , July ... "Company") (TSX-V: EPI) announced today that its common shares have ... Market ("NASDAQ") under the symbol "EPIX". ESSA will ... will retain its listing on the TSX Venture Exchange under ... listing of the common shares on the NASDAQ, each of ...
(Date:7/2/2015)... NYACK, N.Y. , July 2, 2015  Before you ... plan ahead so you can stay safe and healthy. Take ... plants #summersafety. Infographic http://nyackhospital.org/summersafety Protect Your ... rays from the sun can increase your risk of skin ... the shade as much as possible, especially during midday hours. ...
Breaking Medicine Technology:Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4First Aid Summer Survival Tips from Nyack Hospital 2First Aid Summer Survival Tips from Nyack Hospital 3
... Recent breakthroughs in brain,research and technology may have a ... according to scientists visiting the US Senate today. At ... and Pensions,(HELP) researchers from Posit Science, a leading provider ... science lecture and,part hands-on science fair., "Many believe ...
... a First-in-class MRSA-active Bicyclolide, a novel ... macrolide-related drug class, ... the development of small molecule anti-infective drugs, announced,today the initiation ... first-in-class MRSA-active Bicyclolide, a novel,macrolide-related drug class with a distinct ...
Cached Medicine Technology:Senate Told Brain Technology Can Impact Public Policy 2Senate Told Brain Technology Can Impact Public Policy 3Enanta Initiates Phase 1 Study on EDP-322, an Oral Antibiotic With Activity Against Hospital- and Community-Acquired MRSA 2Enanta Initiates Phase 1 Study on EDP-322, an Oral Antibiotic With Activity Against Hospital- and Community-Acquired MRSA 3